4.7 Article

Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cardiac & Cardiovascular Systems

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data

Michael E. Cobble et al.

CARDIOVASCULAR DIABETOLOGY (2012)

Editorial Material Medicine, General & Internal

FDA rejects novel diabetes drug over safety fears

Talha Khan Burki

LANCET (2012)

Article Cardiac & Cardiovascular Systems

Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women

Tobias Pischon et al.

ATHEROSCLEROSIS (2011)

Article Cardiac & Cardiovascular Systems

Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

Meimei Yin et al.

CARDIOVASCULAR DIABETOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

Jose Luis Ferreiro et al.

CIRCULATION (2011)

Article Endocrinology & Metabolism

Hypoglycaemia-induced myocardial infarction as a result of sulphonylurea misuse

B. T. Corley et al.

DIABETIC MEDICINE (2011)

Article Peripheral Vascular Disease

Protective role of adiponectin on endothelial dysfunction induced by AGEs: A clinical and experimental approach

Serena Del Turco et al.

MICROVASCULAR RESEARCH (2011)

Article Public, Environmental & Occupational Health

Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

Henriette Thisted Horsdal et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)

Review Pharmacology & Pharmacy

Vildagliptin A Review of its Use in Type 2 Diabetes Mellitus

Gillian M. Keating

Article Medicine, General & Internal

Severe Hypoglycemia and Risks of Vascular Events and Death.

Sophia Zoungas et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, Research & Experimental

Metalloproteases 2 and 9, Lp-PLA(2) and Lipoprotein Profile in Coronary Patients

Maria Luz Muzzio et al.

ARCHIVES OF MEDICAL RESEARCH (2009)

Review Endocrinology & Metabolism

Factors Contributing to Increased Platelet Reactivity in People With Diabetes

David J. Schneider

DIABETES CARE (2009)

Article Medicine, General & Internal

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Cardiac & Cardiovascular Systems

Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins

U Rauch et al.

ATHEROSCLEROSIS (2000)